{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T18:08:28Z","timestamp":1785002908326,"version":"3.55.0"},"reference-count":142,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008220","name":"Canadian Foundation for AIDS Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008220","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100026269","name":"Ms. Foundation for Women","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100026269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012161","name":"Faculty of Medicine, University of British Columbia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012161","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011094","name":"Public Health Agency of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011094","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005247","name":"University of British Columbia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005247","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jogc.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Obstetrics and Gynaecology Canada"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jogc.2024.102551","type":"journal-article","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T16:22:02Z","timestamp":1715271722000},"page":"102551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Guideline No. 450: Care of Pregnant Women Living with HIV and Interventions to Reduce Perinatal Transmission"],"prefix":"10.1016","volume":"46","author":[{"given":"Andrea","family":"Atkinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Tulloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Boucoiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Money","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogc.2024.102551_bib1","series-title":"World\u2019s AIDS day","year":"2021"},{"key":"10.1016\/j.jogc.2024.102551_bib2","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/00042560-199504120-00011","article-title":"Rates of mother-to-child transmission of HIV-1 in Africa, America, and Europe: results from 13 perinatal studies. The Working Group on Mother-to-Child Transmission of HIV","volume":"8","year":"1995","journal-title":"J\u00a0Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1016\/j.jogc.2024.102551_bib3","series-title":"HIV in Canada: 2020 surveillance highlights","year":"2021"},{"key":"10.1016\/j.jogc.2024.102551_bib4","series-title":"HIV in Canada\u2014surveillance report, 2019","author":"Wa","year":"2021"},{"key":"10.1016\/j.jogc.2024.102551_bib5","doi-asserted-by":"crossref","first-page":"E202","DOI":"10.9778\/cmajo.20180016","article-title":"Missed opportunities for prevention of vertical HIV transmission in Canada, 1997\u20132016: a surveillance study","volume":"6","author":"Bitnun","year":"2018","journal-title":"CMAJ Open"},{"key":"10.1016\/j.jogc.2024.102551_bib6","unstructured":"Singer JS, Laura, Kakkar F, et\u00a0al. Impact of COVID-19 on access to optimal HIV Treatment and vertical transmission: Canadian Perinatal HIV Surveillance Program. The 30th Annual Canadian Conference on HIV \/ AIDS Research; Virtual2021."},{"key":"10.1016\/j.jogc.2024.102551_bib7","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jogc.2017.06.033","article-title":"No. 354-Canadian HIV pregnancy planning guidelines","volume":"40","author":"Loutfy","year":"2018","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2024.102551_bib8","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1016\/j.jogc.2017.04.009","article-title":"No. 185-HIV screening in pregnancy","volume":"39","author":"Keenan-Lindsay","year":"2017","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2024.102551_bib9","doi-asserted-by":"crossref","first-page":"E1448","DOI":"10.1503\/cmaj.170494","article-title":"Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis","volume":"189","author":"Tan","year":"2017","journal-title":"CMAJ"},{"key":"10.1016\/j.jogc.2024.102551_bib10","first-page":"7","article-title":"Canadian Paediatric and Perinatal HIV\/AIDS Research Group consensus recommendations for infant feeding in the HIV context","volume":"8","author":"Khan","year":"2023","journal-title":"J\u00a0Assoc Med Microbiol Infect Dis Can"},{"key":"10.1016\/j.jogc.2024.102551_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081355","article-title":"Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada","volume":"8","author":"Samji","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jogc.2024.102551_bib12","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1186\/s12889-019-6990-z","article-title":"Point-of-care HIV testing best practice for early infant diagnosis: an implementation study","volume":"19","author":"Spooner","year":"2019","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jogc.2024.102551_bib13","series-title":"Human immunodeficiency virus- HIV screening and testing guide","year":"2013"},{"key":"10.1016\/j.jogc.2024.102551_bib14","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1701-2163(15)31053-7","article-title":"Toxoplasmosis in pregnancy: prevention, screening, and treatment","volume":"35","author":"Paquet","year":"2013","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2024.102551_bib15","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S1701-2163(16)32975-9","article-title":"Carrier screening for thalassemia and hemoglobinopathies in Canada","volume":"30","author":"Langlois","year":"2008","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2024.102551_bib16","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jogc.2018.09.020","article-title":"No. 375-clinical practice guideline on the use of first trimester ultrasound","volume":"41","author":"Van den Hof","year":"2019","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2024.102551_bib17","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jogc.2017.01.032","article-title":"No. 348-joint SOGC-CCMG guideline: update on prenatal screening for fetal aneuploidy, fetal anomalies, and adverse pregnancy outcomes","volume":"39","author":"Audibert","year":"2017","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2024.102551_bib18","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S1701-2163(15)30205-X","article-title":"Prenatal diagnosis procedures and techniques to obtain a diagnostic fetal specimen or tissue: maternal and fetal risks and benefits","volume":"37","author":"Wilson","year":"2015","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2024.102551_bib19","series-title":"Therapeutic guidelines: antiretroviral (ARV) treatment of adult HIV infection","year":"2020"},{"key":"10.1016\/j.jogc.2024.102551_bib20","series-title":"Live births, by age of mother. Table 13-10-0416-01","year":"2022"},{"key":"10.1016\/j.jogc.2024.102551_bib21","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1093\/cid\/civ578","article-title":"No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception","volume":"61","author":"Mandelbrot","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jogc.2024.102551_bib22","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/1471-0528.12226","article-title":"Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation","volume":"120","author":"Aziz","year":"2013","journal-title":"BJOG"},{"key":"10.1016\/j.jogc.2024.102551_bib23","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1728-4465.2014.00393.x","article-title":"Intended and unintended pregnancies worldwide in 2012 and recent trends","volume":"45","author":"Sedgh","year":"2014","journal-title":"Stud Fam Plann"},{"key":"10.1016\/j.jogc.2024.102551_bib25","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1086\/650005","article-title":"Factors associated with mother-to-child transmission of HIV-1 despite a maternal viral load <500 copies\/ml at delivery: a case-control study nested in the French perinatal cohort (EPF-ANRS CO1)","volume":"50","author":"Tubiana","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jogc.2024.102551_bib26","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1086\/318530","article-title":"Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies\/ml","volume":"183","author":"Ioannidis","year":"2001","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jogc.2024.102551_bib27","doi-asserted-by":"crossref","first-page":"8S","DOI":"10.1097\/01.AOG.0000662960.32653.80","article-title":"The antiretroviral pregnancy registry: 30 years of monitoring for congenital anomalies [OP04-6D]","volume":"135","author":"Albano","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102551_bib28","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1007\/s10461-018-2111-8","article-title":"Realizing women living with HIV's reproductive rights in the era of ART: the negative impact of non-consensual HIV disclosure on pregnancy decisions amongst women living with HIV in a Canadian setting","volume":"22","author":"Duff","year":"2018","journal-title":"AIDS Behav"},{"key":"10.1016\/j.jogc.2024.102551_bib29","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1177\/1049732315596150","article-title":"Social stigma and childbearing for women living with HIV\/AIDS","volume":"26","author":"Cuca","year":"2016","journal-title":"Qual Health Res"},{"key":"10.1016\/j.jogc.2024.102551_bib30","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/jama.2018.21167","article-title":"HIV viral load and transmissibility of HIV infection: undetectable equals untransmittable","volume":"321","author":"Eisinger","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jogc.2024.102551_bib31","article-title":"Outcome expectancies toward adherence to antiretroviral therapy for pregnant and postpartum women with HIV","volume":"17","author":"Momplaisir","year":"2021","journal-title":"Womens Health (Lond)"},{"issue":"Suppl 7","key":"10.1016\/j.jogc.2024.102551_bib32","article-title":"Optimal timing of viral load monitoring during pregnancy to predict viraemia at delivery in HIV-infected women initiating ART in South Africa: a simulation study","volume":"20","author":"Lesosky","year":"2017","journal-title":"J\u00a0Int AIDS Soc"},{"key":"10.1016\/j.jogc.2024.102551_bib33","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/aogs.14282","article-title":"Perinatal outcomes in women living with HIV-1 and receiving antiretroviral therapy-a systematic review and meta-analysis","volume":"101","author":"Shinar","year":"2022","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jogc.2024.102551_bib34","first-page":"1","article-title":"Revised surveillance case definition for HIV infection--United States, 2014","volume":"63","year":"2014","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jogc.2024.102551_bib35","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.ajog.2020.08.122","article-title":"Variation of CD4 count in pregnant women living with HIV","volume":"223","author":"Byrns","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102551_bib36","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1089\/aid.2007.0059","article-title":"Variation of CD4 count and percentage during pregnancy and after delivery: implications for HAART initiation in resource-limited settings","volume":"23","author":"Ekouevi","year":"2007","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.jogc.2024.102551_bib37","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1086\/508996","article-title":"Reduction in preterm delivery and neonatal mortality after the introduction of antenatal cotrimoxazole prophylaxis among HIV-infected women with low CD4 cell counts","volume":"194","author":"Walter","year":"2006","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jogc.2024.102551_bib38","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/QAI.0000000000000211","article-title":"Safety of cotrimoxazole in pregnancy: a systematic review and meta-analysis","volume":"66","author":"Ford","year":"2014","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jogc.2024.102551_bib39","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S1701-2163(15)30230-9","article-title":"Pre-conception folic acid and multivitamin supplementation for the primary and secondary prevention of neural tube defects and other folic acid-sensitive congenital anomalies","volume":"37","author":"Wilson","year":"2015","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2024.102551_bib40","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1177\/0956462417713432","article-title":"Incidence of disseminated Mycobacterium avium-complex infection in HIV patients receiving antiretroviral therapy with use of Mycobacterium avium-complex prophylaxis","volume":"28","author":"Jung","year":"2017","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.jogc.2024.102551_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/srep32947","article-title":"Rapid HIV viral load suppression in those initiating antiretroviral therapy at first visit after HIV diagnosis","volume":"6","author":"Hoenigl","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jogc.2024.102551_bib42","doi-asserted-by":"crossref","first-page":"E179","DOI":"10.1503\/cmaj.180963","article-title":"Associations between low- and high-dose oral fluconazole and pregnancy outcomes: 3 nested case-control studies","volume":"191","author":"B\u00e9rard","year":"2019","journal-title":"CMAJ"},{"key":"10.1016\/j.jogc.2024.102551_bib43","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12884-015-0684-z","article-title":"Association between maternal HIV infection and low birth weight and prematurity: a meta-analysis of cohort studies","volume":"15","author":"Xiao","year":"2015","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.jogc.2024.102551_bib44","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199904013401301","article-title":"The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies","volume":"340","author":"Andiman","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jogc.2024.102551_bib45","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0140-6736(98)08084-2","article-title":"Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jogc.2024.102551_bib46","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1086\/427287","article-title":"Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy","volume":"40","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jogc.2024.102551_bib47","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/QAD.0b013e3282f9b67a","article-title":"Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000\u20132006","volume":"22","author":"Townsend","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.jogc.2024.102551_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fviro.2022.906271","article-title":"Mother-to-child transmission of HIV within 24 months after delivery in women initiating lifelong antiretroviral therapy pre\/post-conception or postnatally; effects of adolescent girl and young woman status and plasma viremia late in pregnancy","volume":"2","author":"Duri","year":"2022","journal-title":"Front Virol"},{"key":"10.1016\/j.jogc.2024.102551_bib49","doi-asserted-by":"crossref","first-page":"e590","DOI":"10.1093\/cid\/ciac703","article-title":"Update of perinatal human immunodeficiency virus type 1 transmission in France: zero transmission for 5482 mothers on continuous antiretroviral therapy from conception and with undetectable viral load at delivery","volume":"76","author":"Sibiude","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jogc.2024.102551_bib51","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1056\/NEJM199908053410602","article-title":"Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group","volume":"341","author":"Garcia","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jogc.2024.102551_bib52","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/267969","article-title":"HIV mother-to-child transmission, mode of delivery, and duration of rupture of membranes: experience in the current era","volume":"2012","author":"Mark","year":"2012","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102551_bib53","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/1471-0528.13442","article-title":"Duration of ruptured membranes and mother-to-child HIV transmission: a prospective population-based surveillance study","volume":"123","author":"Peters","year":"2016","journal-title":"BJOG"},{"issue":"Suppl 3","key":"10.1016\/j.jogc.2024.102551_bib54","first-page":"s2","article-title":"British HIV Association guidelines for the management of HIV in pregnancy and postpartum 2018","volume":"20","author":"Gilleece","year":"2019","journal-title":"HIV Med"},{"key":"10.1016\/j.jogc.2024.102551_bib55","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/cid\/cit374","article-title":"Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era?","volume":"57","author":"Briand","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jogc.2024.102551_bib56","first-page":"565","article-title":"Intrapartum use of zidovudine in a large cohort of pregnant women living with HIV in Italy","volume":"85","author":"Taramasso","year":"2022","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.jogc.2024.102551_bib57","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1155\/2015\/731043","article-title":"A\u00a0case series of third-trimester raltegravir initiation: impact on maternal HIV-1 viral load and obstetrical outcomes","volume":"26","author":"Boucoiran","year":"2015","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"10.1016\/j.jogc.2024.102551_bib58","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1097\/QAD.0b013e32833d8a50","article-title":"High neonatal concentrations of raltegravir following transplacental transfer in HIV-1 positive pregnant women","volume":"24","author":"McKeown","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.jogc.2024.102551_bib59","first-page":"897","article-title":"Risk factors for perinatal human immunodeficiency virus transmission in patients receiving zidovudine prophylaxis. Pediatric AIDS Clinical Trials Group protocol 076 Study Group","volume":"94","author":"Shapiro","year":"1999","journal-title":"Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.jogc.2024.102551_bib60","first-page":"CD003510","article-title":"Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection","author":"Siegfried","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jogc.2024.102551_bib61","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0140-6736(03)14341-3","article-title":"Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial","volume":"362","author":"Jackson","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jogc.2024.102551_bib62","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/QAI.0000000000000015","article-title":"Long-term follow-up of children in the HIVNET 012 perinatal HIV prevention trial: five-year growth and survival","volume":"64","author":"Owor","year":"2013","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jogc.2024.102551_bib63","series-title":"The National Academies Collection: reports funded by National Institutes of Health. Review of the HIVNET 012 perinatal HIV prevention study","year":"2005"},{"key":"10.1016\/j.jogc.2024.102551_bib64","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/jama.288.2.189","article-title":"Two-dose intrapartum\/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial","volume":"288","author":"Dorenbaum","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jogc.2024.102551_bib65","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/cid\/ciw666","article-title":"Time until emergence of HIV test reactivity following infection with HIV-1: implications for interpreting test results and retesting after exposure","volume":"64","author":"Delaney","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jogc.2024.102551_bib66","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jogc.2017.02.016","article-title":"An evaluation of introduction of rapid HIV testing in a perinatal program","volume":"39","author":"Saunders","year":"2017","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2024.102551_bib67","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S2352-4642(19)30024-0","article-title":"Transmission of CMV, HTLV-1, and HIV through breastmilk","volume":"3","author":"Prendergast","year":"2019","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.jogc.2024.102551_bib68","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/QCO.0000000000000613","article-title":"Undetectable viral load and HIV transmission dynamics on an individual and population level: where next in the global HIV response?","volume":"33","author":"Bavinton","year":"2020","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jogc.2024.102551_bib69","doi-asserted-by":"crossref","first-page":"e531","DOI":"10.1016\/S2352-3018(18)30098-5","article-title":"Does U=U for breastfeeding mothers and infants? Breastfeeding by mothers on effective treatment for HIV infection in high-income settings","volume":"5","author":"Waitt","year":"2018","journal-title":"Lancet HIV"},{"key":"10.1016\/j.jogc.2024.102551_bib70","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/QAI.0000000000001612","volume":"77","author":"Flynn","year":"2018","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jogc.2024.102551_bib71","article-title":"Postnatal HIV transmission in breastfed infants of HIV-infected women on ART: a systematic review and meta-analysis","volume":"20","author":"Bispo","year":"2017","journal-title":"J\u00a0Int AIDS Soc"},{"key":"10.1016\/j.jogc.2024.102551_bib72","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00126334-200312010-00011","article-title":"HIV-1 viral load and other risk factors for mother-to-child transmission of HIV-1 in a breast-feeding population in Cote d'Ivoire","volume":"34","author":"Jamieson","year":"2003","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jogc.2024.102551_bib73","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1086\/420834","article-title":"Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis","volume":"189","author":"Coutsoudis","year":"2004","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jogc.2024.102551_bib74","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1080\/07399332.2014.888720","article-title":"\"Why Aren't You Breastfeeding?\": how Mothers Living With HIV Talk about infant feeding in a \"breast is best\" world","volume":"36","author":"Greene","year":"2015","journal-title":"Health Care Women Int"},{"key":"10.1016\/j.jogc.2024.102551_bib75","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1080\/09540121.2023.2186341","article-title":"Practices, support and stigma related to infant feeding and postpartum engagement in care among women living with HIV in Canada","volume":"35","author":"Boucoiran","year":"2023","journal-title":"AIDS Care"},{"key":"10.1016\/j.jogc.2024.102551_bib76","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0140-6736(15)01024-7","article-title":"Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect","volume":"387","author":"Victora","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jogc.2024.102551_bib77","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1177\/0956462420984694","article-title":"Evaluation of cabergoline for lactation inhibition in women living with HIV","volume":"32","author":"Boucoiran","year":"2021","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.jogc.2024.102551_bib78","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM199411033311801","article-title":"Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group","volume":"331","author":"Connor","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jogc.2024.102551_bib79","series-title":"Recommendations for use of antiretroviral drugs in pregnant women with HIV infection and interventions to reduce perinatal HIV transmission in the United States","year":"2021"},{"key":"10.1016\/j.jogc.2024.102551_bib80","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1056\/NEJMoa1108275","article-title":"Three postpartum antiretroviral regimens to prevent intrapartum HIV infection","volume":"366","author":"Nielsen-Saines","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jogc.2024.102551_bib81","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/COH.0000000000000300","article-title":"Health and survival of HIV perinatally exposed but uninfected children born to HIV-infected mothers","volume":"11","author":"Desmonde","year":"2016","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.jogc.2024.102551_bib82","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1097\/QAI.0000000000000263","article-title":"\"What they wanted was to give birth; nothing else\": barriers to retention in option B+ HIV care among postpartum women in South Africa","volume":"67","author":"Clouse","year":"2014","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jogc.2024.102551_bib83","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1097\/QAD.0b013e328359590f","article-title":"Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis","volume":"26","author":"Nachega","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.jogc.2024.102551_bib84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048168","article-title":"Gender and ethnicity differences in HIV-related stigma experienced by people living with HIV in Ontario, Canada","volume":"7","author":"Loutfy","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jogc.2024.102551_bib85","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/09540121.2016.1211608","article-title":"HIV-related stigma in pregnancy and early postpartum of mothers living with HIV in Ontario, Canada","volume":"29","author":"Ion","year":"2017","journal-title":"AIDS Care"},{"key":"10.1016\/j.jogc.2024.102551_bib86","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1093\/cid\/civ678","article-title":"Postpartum engagement in HIV care: an important predictor of long-term retention in care and viral suppression","volume":"61","author":"Adams","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jogc.2024.102551_bib87","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1089\/jwh.2009.1880","article-title":"Follow-up care among HIV-infected pregnant women in Mississippi","volume":"19","author":"Rana","year":"2010","journal-title":"J\u00a0Womens Health (Larchmt)"},{"key":"10.1016\/j.jogc.2024.102551_bib88","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1089\/apc.2013.0321","article-title":"Predictive factors for loss to postpartum follow-up among low income HIV-infected women in Texas","volume":"28","author":"Siddiqui","year":"2014","journal-title":"AIDS Patient Care STDs"},{"key":"10.1016\/j.jogc.2024.102551_bib89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160775","article-title":"Postpartum loss to HIV care and HIV viral suppression among previously diagnosed HIV-infected women with a live birth in New York State","volume":"11","author":"Swain","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jogc.2024.102551_bib90","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/hiv.12299","article-title":"Postnatal retention in HIV care: insight from the Swiss HIV Cohort Study over a 15-year observational period","volume":"17","author":"Aebi-Popp","year":"2016","journal-title":"HIV Med"},{"key":"10.1016\/j.jogc.2024.102551_bib91","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1089\/apc.2007.0053","article-title":"Prior illicit drug use and missed prenatal vitamins predict nonadherence to antiretroviral therapy in pregnancy: adherence analysis A5084","volume":"22","author":"Cohn","year":"2008","journal-title":"AIDS Patient Care STDs"},{"key":"10.1016\/j.jogc.2024.102551_bib92","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s12888-019-2321-2","article-title":"Prevalence of perinatal depression among HIV-positive women: a systematic review and meta-analysis","volume":"19","author":"Zhu","year":"2019","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jogc.2024.102551_bib93","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S1701-2163(16)30033-0","article-title":"Canadian contraception consensus (part 1 of 4)","volume":"37","author":"Black","year":"2015","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2024.102551_bib94","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.7573\/dic.2020-5-9","article-title":"Potential risk of drug-drug interactions with hormonal contraceptives and antiretrovirals: prevalence in women living with HIV","volume":"9","author":"Murray","year":"2020","journal-title":"Drugs Context"},{"key":"10.1016\/j.jogc.2024.102551_bib95","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/QAD.0000000000001392","article-title":"Drug interactions between hormonal contraceptives and antiretrovirals","volume":"31","author":"Nanda","year":"2017","journal-title":"AIDS (Lond Engl)"},{"key":"10.1016\/j.jogc.2024.102551_bib96","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1517\/17425255.2013.772579","article-title":"Drug interactions between antiretrovirals and hormonal contraceptives","volume":"9","author":"Tseng","year":"2013","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.jogc.2024.102551_bib97","first-page":"411","article-title":"Nucleotide Reverse Transcriptase Inhibitors: A Thorough Review, Present Status and Future Perspective as HIV Therapeutics","volume":"15","author":"Holec","year":"2017","journal-title":"Curr HIV Res"},{"key":"10.1016\/j.jogc.2024.102551_bib99","first-page":"525","article-title":"Growth indices in breastfed infants pre and postnatally exposed to tenofovir compared with tenofovir-unexposed infants","volume":"30","author":"Liotta","year":"2016","journal-title":"Aids"},{"key":"10.1016\/j.jogc.2024.102551_bib100","first-page":"95","article-title":"HIV protease inhibitors: a review of molecular selectivity and toxicity","volume":"7","author":"Lv","year":"2015","journal-title":"HIV AIDS (Auckl)"},{"key":"10.1016\/j.jogc.2024.102551_bib101","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1097\/QAD.0000000000002857","article-title":"Pharmacokinetics of darunavir and cobicistat in pregnant and postpartum women with HIV","volume":"35","author":"Momper","year":"2021","journal-title":"Aids"},{"key":"10.1016\/j.jogc.2024.102551_bib102","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/QAI.0000000000002856","article-title":"Pharmacokinetics of Atazanavir Boosted With Cobicistat in Pregnant and Postpartum Women With HIV","volume":"89","author":"Momper","year":"2022","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jogc.2024.102551_bib103","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/hiv.12721","article-title":"Reduced exposure to darunavir and cobicistat in HIV-1-infected pregnant women receiving a darunavir\/cobicistat-based regimen","volume":"20","author":"Crauwels","year":"2019","journal-title":"HIV Med"},{"key":"10.1016\/j.jogc.2024.102551_bib104","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1468-1293.2011.00927.x","article-title":"Safety and exposure of once-daily ritonavir-boosted atazanavir in HIV-infected pregnant women","volume":"12","author":"Conradie","year":"2011","journal-title":"HIV Med"},{"key":"10.1016\/j.jogc.2024.102551_bib105","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1097\/QAD.0b013e32825a69d1","article-title":"Atazanavir plus low-dose ritonavir in pregnancy: pharmacokinetics and placental transfer","volume":"21","author":"Ripamonti","year":"2007","journal-title":"Aids"},{"key":"10.1016\/j.jogc.2024.102551_bib106","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/QAI.0b013e31820fd093","article-title":"Atazanavir pharmacokinetics with and without tenofovir during pregnancy","volume":"56","author":"Mirochnick","year":"2011","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jogc.2024.102551_bib107","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/hiv.12366","article-title":"Pharmacokinetics of once-daily darunavir\/ritonavir in HIV-1-infected pregnant women","volume":"17","author":"Crauwels","year":"2016","journal-title":"HIV Med"},{"key":"10.1016\/j.jogc.2024.102551_bib108","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/jac\/dku400","article-title":"Pharmacokinetics of total and unbound darunavir in HIV-1-infected pregnant women","volume":"70","author":"Colbers","year":"2015","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jogc.2024.102551_bib109","article-title":"Darunavir pharmacokinetics throughout pregnancy and postpartum","volume":"17","author":"Lambert","year":"2014","journal-title":"J\u00a0Int AIDS Soc"},{"key":"10.1016\/j.jogc.2024.102551_bib110","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3851\/IMP3291","article-title":"Therapeutic drug monitoring of darunavir\/ritonavir in pregnancy","volume":"24","author":"Murtagh","year":"2019","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jogc.2024.102551_bib111","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/jac\/dky567","article-title":"Evaluating darunavir\/ritonavir dosing regimens for HIV-positive pregnant women using semi-mechanistic pharmacokinetic modelling","volume":"74","author":"Schalkwijk","year":"2019","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jogc.2024.102551_bib112","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0301-2115(01)00395-5","article-title":"Hemoglobin concentration in multiple versus singleton pregnancies--retrospective evidence for physiology not pathology","volume":"99","author":"Krafft","year":"2001","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jogc.2024.102551_bib113","first-page":"806","article-title":"Maternal cardiac function in twin pregnancy","volume":"102","author":"Kametas","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102551_bib114","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1053\/j.semperi.2005.08.002","article-title":"Maternal physiology and complications of multiple pregnancy","volume":"29","author":"Norwitz","year":"2005","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.jogc.2024.102551_bib115","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/QAD.0000000000002464","article-title":"Investigation of factors associated with spontaneous preterm birth in pregnant women living with HIV","volume":"34","author":"Albert","year":"2020","journal-title":"Aids"},{"key":"10.1016\/j.jogc.2024.102551_bib116","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/QAD.0b013e32802ef2f6","article-title":"Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis","volume":"21","author":"Kourtis","year":"2007","journal-title":"Aids"},{"key":"10.1016\/j.jogc.2024.102551_bib117","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1097\/QAD.0000000000002593","article-title":"Adverse perinatal outcomes associated with antiretroviral therapy regimens: systematic review and network meta-analysis","volume":"34","author":"Tshivuila-Matala","year":"2020","journal-title":"Aids"},{"key":"10.1016\/j.jogc.2024.102551_bib118","article-title":"Risk factors for pre-term birth in a Canadian cohort of HIV-positive women: role of ritonavir boosting?","volume":"18","author":"Kakkar","year":"2015","journal-title":"J\u00a0Int AIDS Soc"},{"key":"10.1016\/j.jogc.2024.102551_bib119","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/QAI.0000000000002087","article-title":"Stillbirth in Women Living With HIV Delivering in the United Kingdom and Ireland: 2007-2015","volume":"82","author":"Favarato","year":"2019","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jogc.2024.102551_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101368","article-title":"Adverse perinatal outcomes associated with protease inhibitor-based antiretroviral therapy in pregnant women living with HIV: A systematic review and meta-analysis","volume":"46","author":"Cowdell","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jogc.2024.102551_bib121","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejogrb.2011.02.005","article-title":"Atazanavir in pregnancy: impact on neonatal hyperbilirubinemia","volume":"157","author":"Mandelbrot","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jogc.2024.102551_bib122","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1097\/QAI.0b013e31829baf03","article-title":"Maternal atazanavir usage in HIV-infected pregnant women and the risk of maternal and neonatal hyperbilirubinemia","volume":"63","author":"Atrio","year":"2013","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jogc.2024.102551_bib123","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1089\/aid.2013.0002","article-title":"Clinical and pharmacogenetic factors affecting neonatal bilirubinemia following atazanavir treatment of mothers during pregnancy","volume":"29","author":"Eley","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.jogc.2024.102551_bib124","unstructured":"Merck Canada Inc. Isentress\/Isentress HD Product Monograph. Kirkland, QC."},{"key":"10.1016\/j.jogc.2024.102551_bib125","series-title":"Tivicay Product Monograph","year":"2022"},{"key":"10.1016\/j.jogc.2024.102551_bib126","series-title":"Vocabria\/Cabenuva Product Monograph","year":"2022"},{"key":"10.1016\/j.jogc.2024.102551_bib127","series-title":"Biktarvy (bictegravir, emtricitabine, tenofovir alafenamide) Product Monograph","year":"2022"},{"key":"10.1016\/j.jogc.2024.102551_bib128","series-title":"Genovoya (elvitegravir, cobicistat, emtricitabine, tenofovir alafanamide) Product Monograph","year":"2021"},{"key":"10.1016\/j.jogc.2024.102551_bib129","series-title":"Stribild (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate) Product Monograph","year":"2021"},{"key":"10.1016\/j.jogc.2024.102551_bib130","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/psp4.12586","article-title":"A\u00a0population pharmacokinetics analysis assessing the exposure of raltegravir once-daily 1200 mg in pregnant women living with HIV","volume":"10","author":"Bukkems","year":"2021","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1016\/j.jogc.2024.102551_bib131","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1097\/QAD.0000000000003032","article-title":"First pharmacokinetic data of bictegravir in pregnant women living with HIV","volume":"35","author":"Bukkems","year":"2021","journal-title":"Aids"},{"key":"10.1016\/j.jogc.2024.102551_bib132","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/QAD.0000000000002163","article-title":"Cobicistat-containing antiretroviral regimens are not recommended during pregnancy: viewpoint","volume":"33","author":"Boyd","year":"2019","journal-title":"Aids"},{"key":"10.1016\/j.jogc.2024.102551_bib133","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1097\/QAD.0000000000001992","article-title":"Elvitegravir\/cobicistat pharmacokinetics in pregnant and postpartum women with HIV","volume":"32","author":"Momper","year":"2018","journal-title":"Aids"},{"key":"10.1016\/j.jogc.2024.102551_bib134","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/hiv.13439","article-title":"Pregnancy outcomes and pharmacokinetics in pregnant women living with HIV exposed to long-acting cabotegravir and rilpivirine in clinical trials","volume":"24","author":"Patel","year":"2023","journal-title":"HIV Med"},{"key":"10.1016\/j.jogc.2024.102551_bib135","article-title":"Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defects","volume":"22","author":"Mofenson","year":"2019","journal-title":"J\u00a0Int AIDS Soc"},{"key":"10.1016\/j.jogc.2024.102551_bib136","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1111\/1471-0528.15838","article-title":"Congenital anomalies following antenatal exposure to dolutegravir: a Canadian surveillance study","volume":"126","author":"Money","year":"2019","journal-title":"Bjog"},{"key":"10.1016\/j.jogc.2024.102551_bib137","unstructured":"Zash R.; Holmes LB.; Diseko M. JDMG, Mabuta J.; Mmalane M.; Gaolathe T.; Lockman S.; Makhema J.; Shapiro R.;. Update on neural tube defects with antiretroviral exposure in the Tsepamo Study, Botswana. AIDS; July Montreal: QC; 2022."},{"key":"10.1016\/j.jogc.2024.102551_bib140","first-page":"1","article-title":"Non-nucleoside reverse transcriptase inhibitors: a review on pharmacokinetics, pharmacodynamics, safety and tolerability","volume":"16","author":"Usach","year":"2013","journal-title":"J\u00a0Int AIDS Soc"},{"issue":"Suppl 2","key":"10.1016\/j.jogc.2024.102551_bib141","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1097\/QAD.0000000000000231","article-title":"Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis","volume":"28","author":"Ford","year":"2014","journal-title":"Aids"},{"key":"10.1016\/j.jogc.2024.102551_bib142","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1093\/cid\/cix534","article-title":"Lowered Rilpivirine Exposure During the Third Trimester of Pregnancy in Human Immunodeficiency Virus Type 1-Infected Women","volume":"65","author":"Schalkwijk","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jogc.2024.102551_bib143","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/QAI.0000000000000968","article-title":"Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant Women","volume":"72","author":"Tran","year":"2016","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jogc.2024.102551_bib144","doi-asserted-by":"crossref","unstructured":"Viiv Healthcare ULC. Celsentri (Maraviroc) Product Monograph. Laval: QC; 2019.","DOI":"10.26226\/morressier.5b1e3f843b8238060ea91292"},{"key":"10.1016\/j.jogc.2024.102551_bib145","unstructured":"Gilead Sciences Canada Inc. Sunlenca (lenacapravir) Product Monograph. Mississauga: ON; 2022."},{"key":"10.1016\/j.jogc.2024.102551_bib146","unstructured":"Hoffman-La Roche Limited. Fuzeon (enfuvirtide) Product Monograph. Mississauga: ON; 2020."},{"key":"10.1016\/j.jogc.2024.102551_bib147","unstructured":"ViiV Healthcare ULC. Rukobia (fostemsavir) Product Monograph. Montreal: QC; 2023."}],"container-title":["Journal of Obstetrics and Gynaecology Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216324003748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216324003748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T13:04:42Z","timestamp":1731935082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1701216324003748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":142,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1701216324003748"],"URL":"https:\/\/doi.org\/10.1016\/j.jogc.2024.102551","relation":{},"ISSN":["1701-2163"],"issn-type":[{"value":"1701-2163","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guideline No. 450: Care of Pregnant Women Living with HIV and Interventions to Reduce Perinatal Transmission","name":"articletitle","label":"Article Title"},{"value":"Journal of Obstetrics and Gynaecology Canada","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogc.2024.102551","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Society of Obstetricians and Gynaecologists of Canada\/La Soci\u00e9t\u00e9 des obst\u00e9triciens et gyn\u00e9cologues du Canada. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102551"}}